Sign in

CIK 0001133416

  • Non-accelerated filer
  • Smaller reporting company

GALECTIN THERAPEUTICS INC

Sign in to watch
Ticker
GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
043562325
Phone
+1 678-620-3186
Business address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
Former names
PRO PHARMACEUTICALS INC
  1. 4 Grant or award President and CEO acquired 11,010 shares (grant or award)
  2. 4 Grant or award President and CEO acquired 12,042 shares (grant or award)
  3. 4 Grant or award President and CEO acquired 12,844 shares (grant or award)
  4. 4 Open-market buy Director bought 1,598 shares at $1.79 ($2,854)
  5. 4 Grant or award President and CEO acquired 11,820 shares (grant or award)
  6. 4 Grant or award President and CEO acquired 13,380 shares (grant or award)
  7. 4 Grant or award President and CEO acquired 13,196 shares (grant or award)
  8. 4 Grant or award President and CEO acquired 12,272 shares (grant or award)
  9. 4 Grant or award President and CEO acquired 11,748 shares (grant or award)
  10. 4 Grant or award President and CEO acquired 10,947 shares (grant or award)
  11. 4 Grant or award President and CEO acquired 9,585 shares (grant or award)
  12. 4 Grant or award President and CEO acquired 9,175 shares (grant or award)
  13. 4 Grant or award President and CEO acquired 10,140 shares (grant or award)
  14. 4 Shares withheld for taxes President and CEO gave up 75,529 shares (to pay taxes)
  15. 4 Open-market buy Director bought 1,000 shares at $1.59 ($1,591)
  16. 4 Open-market buy President and CEO bought 1,000 shares at $1.52 ($1,520)
  17. 4 Grant or award President and CEO acquired 13,380 shares (grant or award)
  18. 4 Grant or award President and CEO acquired 143,836 shares (grant or award)
  19. 4 Grant or award President and CEO acquired 15,086 shares (grant or award)
  20. 5 Insider Annual Insider Trading Report

Page 7 of 39 · 776 filings